The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127258511 12725851 1 I 20160829 20160908 20160908 EXP PL-TEVA-690447ISR TEVA HANNA K-J, AGNIESZKA K-P, MICHAL D, DARIUSZ J, IZABELA D, AGATA M, ET AL. AFFECTIVE DISORDERS AS POTENTIAL COMPLICATION OF ANTI-ACNE TREATMENT WITH ISOTRETINOIN: A CASE SERIES. J-AFFECT-DISORD 2016;204:154-158. 18.00 YR F Y 0.00000 20160908 OT PL PL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127258511 12725851 1 PS ISOTRETINOIN ISOTRETINOIN 1 Oral 30 MILLIGRAM DAILY; 1.4 G 76135

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127258511 12725851 1 Acne

Outcome of event

Event ID CASEID OUTC COD
127258511 12725851 OT
127258511 12725851 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127258511 12725851 Major depression
127258511 12725851 Suicidal ideation
127258511 12725851 Suicide attempt

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found